Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Anaemia
ADR ID BADD_A00178
ADR Hierarchy
01      Blood and lymphatic system disorders
01.03      Anaemias nonhaemolytic and marrow depression
01.03.02      Anaemias NEC
01.03.02.001      Anaemia
Description A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. [MeSH]
MedDRA Code 10002034
MeSH ID D000740
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Anaemia | Anaemia aggravated | Anaemia NOS | Anaemia NOS aggravated | Anaemia, unspecified | Anaemias, other and unspecified | Anaemic | Anemia | Anemia, unspecified | Other and unspecified anaemias | Other and unspecified anemias | Other specified anaemias | Other specified anemias | Secondary anaemia | Unspecified anemia | Anemia aggravated | Secondary anemia | Unspecified anaemia | Anemic | Anaemia post chemotherapy | Anemia post chemotherapy | Acute anemia | Acute anaemia | Chronic anaemia | Chronic anemia | Dimorphic anemia | Dimorphic anaemia | Transfusion dependent anemia | Transfusion dependent anaemia | Anemias
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Mitogen-activated protein kinase 14Q16539T65864
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00172Asenapine--
BADD_D00178Atenolol--
BADD_D00179Atezolizumab--
BADD_D00182Atorvastatin calcium--
BADD_D00186Atovaquone--
BADD_D00191Auranofin--
BADD_D00193Axitinib--
BADD_D00194Azacitidine0.043159%
BADD_D00195Azathioprine0.033028%
BADD_D00203Azithromycin--
BADD_D00206Aztreonam--
BADD_D00207Bacillus calmette-guerin--
BADD_D00209Baclofen--
BADD_D00210Balsalazide--
BADD_D00214Basiliximab--
BADD_D00223Belatacept--
BADD_D00225Belinostat--
BADD_D00230Bendamustine0.004263%
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00235Benzalkonium chloride--
BADD_D00263Betaxolol--
BADD_D00269Bexarotene0.000799%
BADD_D00270Bezafibrate--
BADD_D00271Bicalutamide0.087000%
BADD_D00277Bisoprolol0.016771%
BADD_D00279Bivalirudin--
BADD_D00280Bleomycin0.002131%
BADD_D00282Blinatumomab--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib0.014386%
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 31 Pages